Skip to main content

Welcome to the CRL Insurer Services blog! Here you will find commentary from our dedicated team of medical directors and industry leaders on lab research and trends, innovative services and solutions, and what’s new at CRL. Click the button below to get the latest news directly to your inbox. Questions? Contact us at ILSsales@crlcorp.com.

Sign Up for Updates

 

New Data: Leading Causes of Death in the U.S. are Changing

April 7, 2022

Consulting medical director Michael Fulks, MD, comments on recent changes to the leading causes of death because of COVID-19, drugs,… Read More

Tags: Cancer, Covid 19, Drug overdose, Life Insurance, Mortality

COVID-19 Long-Haul Effects

August 5, 2021

CRL Chief Scientific Officer Dr. Robert Stout discusses the lasting impact of COVID-19 infection in both symptomatic and asymptomatic patients…. Read More

Tags: Covid 19, Covid 19 Crisis, Laboratory, Life Insurance, Mortality

Marijuana Use During the COVID-19 Pandemic

July 8, 2021

Dr. Steven J. Rigatti explores marijuana use during the COVID-19 pandemic as a follow-up to earlier commentary on alcohol and tobacco use…. Read More

Tags: Alcohol, Covid 19, Laboratory, Marijuana, Pandemic

2020 US Mortality Results: How do they compare to prior years?

June 17, 2021

Dr. Michael Fulks, Consulting Medical Director to CRL, comments on the 2020 leading causes of death in a COVID-19 world…. Read More

Tags: Cancer, Covid 19, Heart Disease, Life Insurance, Mortality

Bad Habits and the Pandemic

March 10, 2021

Dr. Steven Rigatti, Consulting Medical Director to CRL, comments on alcohol and tobacco usage rates from a pre-pandemic period to… Read More

Tags: Alcohol, Covid 19, Covid 19 Crisis, Pandemic, Stay At Home

New CRL COVID-19 Research: Viral Load in Asymptomatic vs. Symptomatic Cases is Similar

February 22, 2021

A new paper on COVID-19 research from CRL doctors was published this week. Over 460k samples collected from July 2020… Read More

Tags: Covid 19, Covid 19 Crisis, Covid 19 Testing, Covid Update, Data

COVID-19 Antibody Prevelance Increased throughout 2020: New Research from CRL

January 7, 2021

Dr. Robert Stout, Co-Founder and Chief Scientific Officer at CRL, and Dr. Steven Rigatti, Consulting Medical Director with CRL, conducted… Read More

Tags: Coronavirus, Covid 19, Covid 19 Crisis, Life Insurance, Risk Management

CRL Receives FDA Emergency Use Authorization for Best-in-Class Self-Collected COVID-19 Saliva Test

August 3, 2020

CRL has received FDA Emergency Use Authorization (EUA) and is scaling up capacity for CRL Rapid Response™, a saliva-based COVID-19… Read More

Tags: Coronavirus, Covid 19, Covid 19 Crisis, Covid 19 Testing, FDA

COVID-19 Research Updates & Resources: April 22

April 22, 2020

As COVID-19 continues to be top of mind, we are committed to serving our customers and understanding the virus. There… Read More

Tags: Coronavirus, Covid 19, Covid 19 Crisis, Laboratory, Molecular Diagnostics

COVID-19 Crisis & CRL: Serving the Life Behind Each Sample

March 31, 2020

We are closely monitoring events pertaining to the COVID-19 crisis and are working hard to ensure our customers are informed… Read More

Tags: Covid 19, Life Insurance, Mortality

If you would like to sign up to receive email updates from the Insurer team, please click here.